(Q44544248)

4 December 2017

Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years (English)

1 reference

4 December 2017

1 reference

1 reference

Charles Oo

1

0 references

Penelope Ward

object named as

Penelope Ward

6

0 references

author name string

George Hill

2

1 reference

4 December 2017

Albert Dorr

3

1 reference

4 December 2017

Baolian Liu

4

1 reference

4 December 2017

Samuel Boellner

5

1 reference

4 December 2017

9 August 2003

1 reference

European Journal of Clinical Pharmacology

4 December 2017

1 reference

4 December 2017

59

1 reference

4 December 2017

411-415

1 reference

4 December 2017

5-6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-003-0639-6

4 December 2017

0 references

cites work

Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine.

1 reference

12 December 2020

Effect of maturation on drug disposition in pediatric patients

1 reference

12 December 2020

Influenza and the rates of hospitalization for respiratory disease among infants and young children

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Oral oseltamivir treatment of influenza in children.

1 reference

12 December 2020

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

1 reference

12 December 2020

Developmental patterns of renal functional maturation compared in the human neonate

1 reference

12 December 2020

The impact of influenza epidemics on hospitalizations.

1 reference

12 December 2020

Developmental changes in hepatic esterase activity towards chloramphenicol succinate and its Michaelis-Menten constant of liver, kidney and lung in human.

1 reference

12 December 2020

Drug trials in children: problems and the way forward

1 reference

12 December 2020

Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children

1 reference

12 December 2020

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

12 December 2020

10.1007/S00228-003-0639-6

Identifiers

DOI

1 reference

4 December 2017

1 reference